activationacuteadamts13adultadultsagingallogeneicamlanemiaantiantibodiesantibodyantigenaplaplasticasciminibassessmentassociatedbispecificbleedingbonecancercd19celcellcellschemotherapychildrenchronicclassicalclinicalcllclonalcmlcnscombinationcovidcytokinediagnoseddiagnosisdiffusediseasedisordersdlbcldonordrivesdualearlyeffectsfactorfailurefirstfixedfollicularfunctiongenegeneticgenomicgermlinegvhdhaploidenticalhcthematologichematopoiesishematopoietichemophiliahighhlhhodgkinhomeostasishschscthumanibrutinibimmuneimmunityimpactinducedinductioninflammationinhibitioninhibitorinhibitorsinsightsironitpkinaselargelenalidomideleukemialeukemiaslinelonglosslymphoblasticlymphomalymphomasmacrophagemaintenancemalignanciesmalignancymantlemarrowmdsmechanismsmicroenvironmentmmmodelmolecularmonoclonalmrdmultiplemutantmutatedmutationsmyelodysplasticmyelofibrosismyeloidmyelomanegativeneoplasmsneutrophilnewlynknovelnpm1obinutuzumabolderoutcomespatientspdpediatricpembrolizumabplateletplateletspluspositivepostpredictionpreventionprimaryprognosticpromotesprophylaxisrapidrealreceptorrefractoryrelapserelapsedrelatedresearchresistanceresponsereviewriskrituximabroleruxolitinibscdseasonseriesseveresicklesignalingspecificstemstratificationstrokesurvivalsyndromesyndromestargetedtargetingtermthalassemiatherapythrombocytopeniathrombosisthrombotictp53transplanttransplantationtreattreatedtreatmenttrialttptypeusingvaccinationvariantsvenetoclaxvenousversusvexasvtevwfwillebrandworld